Yinon Ben-Neriah

5PUBLICATIONS
14CO-AUTHORS
Neurology and neuromuscular diseasesPredictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 12, 2024
Inhibition of nucleo-cytoplasmic proteasome translocation by the aromatic amino acids or silencing Sestrin3-their sensing mediator-is tumor suppressive.

Ido Livneh, Bertrand Fabre, Gilad Goldhirsh

|Jan 22, 2024
Tissue-Predisposition to Cancer Driver Mutations.

Luriano Peters, Avanthika Venkatachalam, Yinon Ben-Neriah

|Dec 26, 2023
Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in Myc induction can promote leukemic transformation.

Stijn N R Fuchs, Ursula S A Stalmann, Inge A M Snoeren

|Oct 14, 2021
Immunity in acute myeloid leukemia: Where the immune response and targeted therapy meet.

Avner Fink, Eric Hung, Indranil Singh

|Oct 01, 2017
Casein kinase 1-epsilon or 1-delta required for Wnt-mediated intestinal stem cell maintenance.

Yael Morgenstern, Upasana Das Adhikari, Muneef Ayyash

Pageof 1

Frequent Collaborators

1 joint publications

Muneef Ayyash

1 joint publications

Andreas Moor

1 joint publications

Shalev Itzkovitz

1 joint publications

Stephani Schmitz